Apollo Health Ventures (Group)

Apollo Health Ventures is an early-stage investment firm based in Europe and the U.S. focusing on translating breakthrough discoveries in geroscience. Apollo Health Ventures focuses on assets, platforms and modalities with the potential to treat, prevent, or even reverse age-related diseases such as neurodegenerative disease, cardiovascular disease, sarcopenia, frailty, and cancer, with the ultimate goal of increasing healthy human lifespan. Apollo actively works with scientists and entrepreneurs to create new ventures, and engages in hypothesis-driven company building. *

	Start	2019-02-26 existent
	Today	Apollo Ventures Holding GmbH (Apollo Health Ventures, AHV)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Regge, Nils (Apollo Health Ventures 202305 Managing Director)

	Region	Hamburg
	Country	Germany

Basic data	Employees	n. a.

		* Document for »About Section«: Aeovian Pharmaceuticals Inc.. (10/3/19). "Press Release: Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases". San Francisco, CA.

		Record changed: 2023-12-30

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Apollo Health Ventures (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]